Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix W Frueh

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Clinical Chemistry and Laboratory Medicine|May 16, 2003
The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogeneticsFelix W Frueh, Mario Noyer-Weidner
Drug Discovery Today. Technologies|July 2, 2014
Questions and answers about the Pilot Process for Biomarker Qualification at the FDAFederico M Goodsaid, Felix W Frueh
Personalized Medicine|May 24, 2018
Pharmacogenomics steps toward personalized medicineHong-Guang Xie, Felix W Frueh
Drug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William Mattes
Toxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William Mattes
Journal of Personalized Medicine|January 7, 2015
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing InformationEric J Stanek, Christopher L Sanders, Felix W Frueh
Biomarkers in Medicine|May 19, 2010
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspectiveShashi Amur, Felix W Frueh, Lawrence J Lesko, et al.
Pharmacogenomics|December 24, 2008
4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007Felix W Frueh, Ronald A Salerno, Lawrence J Lesko, et al.
Nature Reviews. Genetics|June 2, 2011
The future of direct-to-consumer clinical genetic testsFelix W Frueh, Henry T Greely, Robert C Green, et al.
Drug Discovery Today. Technologies|July 2, 2014
An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path InitiativeWeida Tong, Stephen C Harris, Hong Fang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Chemistry and Laboratory Medicine|May 16, 2003
The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogeneticsFelix W Frueh, Mario Noyer-Weidner
Drug Discovery Today. Technologies|July 2, 2014
Questions and answers about the Pilot Process for Biomarker Qualification at the FDAFederico M Goodsaid, Felix W Frueh
Personalized Medicine|May 24, 2018
Pharmacogenomics steps toward personalized medicineHong-Guang Xie, Felix W Frueh
Drug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William Mattes
Toxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William Mattes
Journal of Personalized Medicine|January 7, 2015
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing InformationEric J Stanek, Christopher L Sanders, Felix W Frueh
Biomarkers in Medicine|May 19, 2010
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspectiveShashi Amur, Felix W Frueh, Lawrence J Lesko, et al.
Pharmacogenomics|December 24, 2008
4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007Felix W Frueh, Ronald A Salerno, Lawrence J Lesko, et al.
Nature Reviews. Genetics|June 2, 2011
The future of direct-to-consumer clinical genetic testsFelix W Frueh, Henry T Greely, Robert C Green, et al.
Drug Discovery Today. Technologies|July 2, 2014
An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path InitiativeWeida Tong, Stephen C Harris, Hong Fang, et al.
Pageof 3